Latest Press Releases

Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers

June 27, 2024

Read More at Our Investor Site

Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform

June 3, 2024

Read More at Our Investor Site



Receive Email Alerts

Media Contact

Melissa Downs

Senior Director, Corporate Communications
646-975-2533

media@lantheus.com

Investors

Mark Kinarney

Vice President, Investor Relations
978-671-8842

ir@lantheus.com